tiprankstipranks
Trending News
More News >
Waystar Holding Corp. (WAY)
NASDAQ:WAY
US Market

Waystar Holding Corp. (WAY) AI Stock Analysis

Compare
220 Followers

Top Page

WAY

Waystar Holding Corp.

(NASDAQ:WAY)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
$27.00
▲(12.55% Upside)
Waystar Holding Corp. shows strong financial performance and positive earnings call highlights, particularly with its revenue growth and strategic acquisition. However, the stock's technical indicators suggest a bearish trend, and its high P/E ratio indicates potential overvaluation. These factors contribute to a balanced overall score.
Positive Factors
Revenue Growth & Margin
Waystar's 12% YoY revenue increase to $269M alongside a 42% adjusted EBITDA margin demonstrates scalable recurring revenue and strong operational leverage. Sustained top-line growth with high EBITDA margins supports continued investment in product, sales, and AI capabilities over multiple quarters.
Strong Cash Generation
Robust cash conversion—high operating cash flow relative to net income and FCF near net income—indicates Waystar reliably turns earnings into cash. This durable cash generation reduces refinancing risk, funds organic investments and M&A, and supports longer-term product development and balance sheet resilience.
Strategic Acquisition (Iodine)
The Iodine acquisition materially expands addressable market and client footprint, adding nearly 150 health systems and over 1,000 hospitals and accelerating the AI mid-cycle roadmap by ~2 years. This strengthens cross-sell opportunities and durable market positioning in healthcare revenue cycle tech.
Negative Factors
Low Net Profit Margin
A modest net margin (8.5%) versus strong gross (67.3%) and EBIT (20.8%) margins suggests substantial non-operating costs or tax/interest drag. Persistently low net profitability can limit retained earnings for reinvestment, constrain ROE improvement, and reduce resilience to margin pressure.
Data Fragmentation Risks
Waystar flags data fragmentation that reduces AI effectiveness. Because healthcare data remains siloed and inconsistent, this is a structural challenge that can slow AI-driven differentiation, increase customer onboarding costs, and limit the pace at which automated denial prevention and recovery scale across clients.
Integration & Cybersecurity
Complex EHR integrations and cybersecurity demands create persistent implementation and compliance costs. These structural hurdles can delay deployments, raise engineering and support expenses, and increase reputational and regulatory risk, potentially slowing enterprise adoption and contract conversion rates.

Waystar Holding Corp. (WAY) vs. SPDR S&P 500 ETF (SPY)

Waystar Holding Corp. Business Overview & Revenue Model

Company DescriptionWaystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.
How the Company Makes MoneyWaystar generates revenue through a subscription-based model, offering its software solutions to healthcare providers, which include hospitals, clinics, and outpatient facilities. The company charges fees for access to its platform, which encompasses various services such as claims management, patient billing, and analytics. Key revenue streams include recurring subscription fees, transaction fees associated with payment processing, and additional services like consulting and support. Partnerships with healthcare organizations and technology providers also contribute significantly to its revenue, as they expand Waystar's market reach and enhance service offerings.

Waystar Holding Corp. Earnings Call Summary

Earnings Call Date:Oct 29, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 17, 2026
Earnings Call Sentiment Positive
Waystar demonstrated robust revenue growth, successful acquisition integration, and significant AI-driven innovations, although challenges remain in data integration and cybersecurity. The positive client feedback and increased financial guidance reflect strong market positioning.
Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Waystar reported a 12% year-over-year revenue growth, reaching $269 million, with an adjusted EBITDA margin of 42%.
Acquisition of Iodine Software
Waystar completed the acquisition of Iodine Software, expanding the total addressable market by more than 15% and adding nearly 150 health systems to its client base.
AI-Powered Platform Innovations
Waystar introduced new AI-powered capabilities focusing on denial prevention, denial recovery, and patient financial engagement, leading to significant efficiency improvements.
Positive Client Feedback
Waystar reported a 93% confidence level from clients as a trusted partner and received two prestigious awards: Best Workplaces for Innovators in North America and Healthcare Company of the Year.
Financial Guidance Increase
Waystar raised its full-year revenue guidance to $1.085 billion to $1.093 billion and adjusted EBITDA guidance to $451 million to $455 million.
Negative Updates
Challenges in Data Fragmentation
Waystar noted ongoing challenges with data fragmentation, impacting the effectiveness of AI initiatives due to incomplete or inconsistent data.
Integration and Cybersecurity Concerns
Despite advancements, integration with existing systems and cybersecurity remain critical challenges as AI becomes increasingly embedded in processes.
Potential Seasonality Impact
Volume-based revenue decreased 4% sequentially, attributed to seasonality and a reversion of patient utilization to historical growth rates.
Company Guidance
In the Waystar Third Quarter 2025 Earnings Conference Call, the company reported strong financial performance with revenue growing to $269 million, marking a 12% year-over-year increase, and achieving an adjusted EBITDA margin of 42%. The company surpassed its guidance on both revenue and margins. Waystar's strategic acquisition of Iodine Software expanded its total addressable market by over 15%, adding nearly 150 health systems and more than 1,000 hospitals to its client base. The integration of Iodine's AI-powered mid-cycle capabilities is expected to accelerate Waystar's product roadmap by nearly two years. Waystar's platform, which integrates with over 500 electronic health records, serves over one million providers nationwide, emphasizing its role in modernizing the healthcare payment process. The company showcased its AI-driven innovations at the Waystar True North conference, highlighting significant improvements in denial prevention and recovery, which are critical given the $20 billion annual denial issue in healthcare. The company also noted a net revenue retention rate of 113% and raised its full-year revenue guidance to a range of $1.085 billion to $1.093 billion, with an expected adjusted EBITDA margin of approximately 42%.

Waystar Holding Corp. Financial Statement Overview

Summary
Waystar Holding Corp. demonstrates solid financial health with strong revenue growth and efficient cash flow management. While profitability metrics are strong, there is potential for enhancing net profit margins and return on equity to maximize shareholder value.
Income Statement
78
Positive
Waystar Holding Corp. has shown a consistent revenue growth trajectory, with a TTM revenue growth rate of 2.82%. The company maintains strong gross and EBIT margins at 67.32% and 20.80% respectively, indicating efficient cost management and operational profitability. However, the net profit margin is relatively low at 8.50%, suggesting room for improvement in net profitability.
Balance Sheet
72
Positive
The balance sheet reflects a stable financial position with a low debt-to-equity ratio of 0.40, indicating prudent leverage management. The equity ratio stands at 67.90%, showcasing a strong equity base. However, the return on equity is modest at 2.77%, suggesting limited returns on shareholder investments.
Cash Flow
85
Very Positive
Cash flow analysis reveals robust free cash flow growth of 2.14% in the TTM, with a strong operating cash flow to net income ratio of 1.99. The free cash flow to net income ratio is high at 91.45%, indicating effective cash generation relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.04B943.55M791.01M704.87M578.57M
Gross Profit704.77M627.82M541.24M489.98M426.80M
EBITDA380.67M310.36M318.55M272.62M236.37M
Net Income111.18M-19.13M-51.33M-51.45M-47.12M
Balance Sheet
Total Assets4.75B4.58B4.58B4.69B4.78B
Cash, Cash Equivalents and Short-Term Investments421.06M182.13M45.43M64.56M47.25M
Total Debt40.73M1.26B2.25B2.26B2.30B
Total Liabilities1.52B1.50B2.53B2.59B2.66B
Stockholders Equity3.22B3.08B2.05B2.11B2.12B
Cash Flow
Free Cash Flow284.52M142.50M29.94M85.20M91.86M
Operating Cash Flow307.81M169.77M51.46M102.63M106.41M
Investing Cash Flow-23.29M-27.27M-61.52M-17.43M-444.33M
Financing Cash Flow16.49M16.65M-17.15M-67.06M331.50M

Waystar Holding Corp. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price23.99
Price Trends
50DMA
31.88
Negative
100DMA
34.53
Negative
200DMA
36.24
Negative
Market Momentum
MACD
-1.99
Positive
RSI
19.15
Positive
STOCH
5.52
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WAY, the sentiment is Negative. The current price of 23.99 is below the 20-day moving average (MA) of 29.31, below the 50-day MA of 31.88, and below the 200-day MA of 36.24, indicating a bearish trend. The MACD of -1.99 indicates Positive momentum. The RSI at 19.15 is Positive, neither overbought nor oversold. The STOCH value of 5.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for WAY.

Waystar Holding Corp. Risk Analysis

Waystar Holding Corp. disclosed 58 risk factors in its most recent earnings report. Waystar Holding Corp. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Waystar Holding Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$5.15B21.1325.96%14.43%29.86%
72
Outperform
$3.15B52.9011.81%44.34%45.96%
71
Outperform
$6.61B12.3622.32%1.41%7.40%-14.45%
71
Outperform
$4.42B12.4923.75%1.69%-0.38%31.38%
68
Neutral
$10.21B27.0810.21%14.26%-15.49%
68
Neutral
$4.59B39.253.54%14.75%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
WAY
Waystar Holding Corp.
24.13
-16.81
-41.06%
EPAM
Epam Systems
184.78
-79.48
-30.08%
EXLS
Exlservice Holdings
32.46
-19.34
-37.34%
G
Genpact
38.34
-10.32
-21.22%
SAIC
Science Applications
97.87
-6.86
-6.55%
PAY
Paymentus Holdings
24.37
-7.89
-24.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 10, 2025